Research Article| Volume 84, ISSUE 5, P698-707, November 1974

Suppression of activities of carbohydrate-metabolizing enzymes in adipose tissue of obese humans by clofibrate

      This paper is only available as a PDF. To read, Please Download here.


      We studied the effects of insulin, epinephrine, and clofibrate on the activities of carbohydrate-metabolizing enzymes in adipose tissue of 8 obese human volunteer subjects. In all patients, clofibrate decreased the activities of pyruvate kinase, phosphofructokinase, fructose diphosphate aldolase, and fructose diphosphatase after 7 days of treatment. In 4 patients studied in more detail, insulin produced a significant increase in pyruvate kinase and phosphofructokinase activities and a significant decrease in fructose diphosphatase within 5 minutes. Epinephrine injection produced opposite effects. Clofibrate decreased these responses to both insulin and epinephrine. Clofibrate may act at the plasma membrane of the adipose cell to inhibit the lipolytic effects of epinephrine and the antilipolytic effects of insulin.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zakim D
        • Pardini RS
        • Herman RH
        Effect of clofibrate (ethylchlorophenoxyisobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat.
        Biochem Pharmacol. 1970; 19: 305-310
        • Zakim D
        • Hermam RH
        • Rosensweig NS
        • et al.
        Clofibrate-induced changes in the activity of human intestinal enzymes.
        Gastroenterology. 1969; 56: 496-499
        • Bücher T
        • Pfleiderer G
        Pyruvate kinase from muscle.
        in: Ed. 10. Methods in Enzymology. vol. I. Academic Press, New York1955: 435
        • Lea MA
        • Walker DG
        Factors affecting hepatic glycolysis and some changes that occur during development.
        Biochem J. 1965; 94: 655-665
        • Spolter PD
        • Adelman RC
        • Weinhouse S
        Distinctive properties of native and carboxypeptidase-treated aldolases of rabbit muscle and liver.
        J. Biol Chem. 1965; 240: 1327-1337
        • Racker E
        Fructose-1,6-diphosphatase from spinach leaves.
        in: Ed. 10. Methods in Enzymology. vol. V. Academic Press, New York1962: 272
        • Lowry OH
        • Rosenbough NJ
        • Farr AL
        • et al.
        Protein measurement with the folin phenol reagent.
        J Biol Chem. 1951; 193: 265-275
        • Taunton OD
        • Stifel FB
        • Greene HL
        • et al.
        Rapid reciprocal changes of rat hepatic glycolytic enzymes and fructose-1,6-diphosphatase following glucagon and insulin injection in vivo.
        Biochem Biophys Res Commun. 1972; 48: 1663-1670
        • Rosensweig NS
        • Stifel FB
        • Herman RH
        • et al.
        The dietary regulation of the glycolytic enzymes. II. Adaptive changes in human jejunum.
        Biochim Biophys Acta. 1968; 170: 228-234
        • Stifel FB
        • Herman RH
        • Rosensweig NS
        Dietary regulation of glycolytic enzymes. III. Adaptive changes in rat jejunal pyruvate kinase, phosphofructokinase, fructosediphosphatase, and glycerol-3-phosphate dehydrogenase.
        Biochim Biophys Acta. 1969; 184: 29-34
        • Eaton RP
        Effect of clofibrate on arginine-induced insulin and glucagon secretion.
        Metabolism. 1973; 22: 763-767
        • Nestel PJ
        • Austin W
        The effect of ethyl chlorophenoxyisobutyrate (CPIB) on the uptake of triglyceride fatty acids, activity of lipoprotein lipase, and lipogenesis from glucose in fat tissue of rats.
        J Atheroseler Res. 1968; 8: 827-833
        • Bierman EI
        • Brunzell JD
        • Bagdade JD
        • et al.
        On the mechanism of action of Atromid-S on triglyceride transport in man.
        Trans Assoc Am Phys. 1970; 83: 211-224
        • Gould RG
        • Swyryd EA
        • Coan BJ
        • et al.
        Effects of chlorophenoxyisobutyrate (CPIB) on liver composition and triglyceride synthesis in rats.
        J Atheroscler Res. 1966; 6: 555-564
        • Maragoudakis ME
        On the mode of action of lipid-lowering agents. II. In vitro inhibition of acetyl coenzyme A carboxylase by a hypolipidemic drug.
        Biochemistry. 1970; 9: 413-417
        • Adams LL
        • Webb WW
        • Fallon HJ
        Inhibition of hepatic triglyceride formation by clofibrate.
        J Clin Invest. 1971; 50: 2339-2346
        • White LW
        Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
        J Pharmacol Exp Therap. 1971; 178: 361-370
        • Avoy DR
        • Swyryd EA
        • Gould RG
        Effects of a-p-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liver.
        J Lipid Res. 1965; 6: 369-376
        • Horlick L
        • Kudchodkar BJ
        • Sodhi HS
        Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man.
        Circulation. 1971; 43: 299-309
        • Greene HL
        • Herman RH
        • Zakim D
        The effect of clofibrate on rat tissue adenyl cyclase.
        in: Ed. 10. Proc Soc Exp Biol Med. 134. 1970: 1035-1038
        • D'Costa M
        • Angel A
        Inhibition of hormone stimulated lipolysis by elofibrate; mechanism for its hypolipidemic effect.
        Clin Res. 1973; 21: 884
        • Fain JN
        Biochemical aspects of drugs and hormone action on adipose tissue.
        Pharmacol Rev. 1973; 25: 67-118